WINT Projected Dividend Yield
Com Par $0.001 (New) 2024/Windtree Therapeutics Inc ( NASDAQ : WINT )Windtree Therapeutics, Inc. is a biotechnology company. Co. is focused on advancing early and late-stage therapies for critical conditions and diseases. Co.'s portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, pre-clinical SERCA2a activators for heart failure and VAR-101 and VAR-102, pre-clinical precision atypical protein kinase C iota (aPKCi) inhibitors that are being developed for potential in rare and broad oncology applications. 20 YEAR PERFORMANCE RESULTS |
WINT Dividend History Detail WINT Dividend News WINT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |